{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:38:13Z","timestamp":1788885493821,"version":"build-2803163510"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0235362","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T17:43:45Z","timestamp":1593107025000},"page":"e0235362","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["A novel selective PPAR\u03b1 modulator, pemafibrate promotes ischemia-induced revascularization through the eNOS-dependent mechanisms"],"prefix":"10.1371","volume":"15","author":[{"given":"Hiroshi","family":"Kawanishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9666-026X","authenticated-orcid":true,"given":"Koji","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Otaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonobu","family":"Takikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikito","family":"Takefuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,6,25]]},"reference":[{"issue":"4","key":"pone.0235362.ref001","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","article-title":"Heart disease and stroke statistics\u20142011 update: a report from the American Heart Association","volume":"123","author":"VL Roger","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"pone.0235362.ref002","first-page":"e13","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"24","author":"SM Grundy","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"pone.0235362.ref003","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/sj.ijo.0802474","article-title":"Obesity is associated with impaired coronary collateral vessel development","volume":"27","author":"MB Yilmaz","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"5","key":"pone.0235362.ref004","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00019501-200508000-00004","article-title":"Impaired coronary collateral vessel development in patients with metabolic syndrome","volume":"16","author":"H Turhan","year":"2005","journal-title":"Coron Artery Dis"},{"issue":"19","key":"pone.0235362.ref005","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","article-title":"Mechanism of action of fibrates on lipid and lipoprotein metabolism","volume":"98","author":"B Staels","year":"1998","journal-title":"Circulation"},{"issue":"3","key":"pone.0235362.ref006","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00041433-199906000-00007","article-title":"Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis","volume":"10","author":"JC Fruchart","year":"1999","journal-title":"Curr Opin Lipidol"},{"issue":"12","key":"pone.0235362.ref007","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/14779072.2017.1408410","article-title":"Fibrates in the management of atherogenic dyslipidemia","volume":"15","author":"B Okopien","year":"2017","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"5","key":"pone.0235362.ref008","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/FJC.0b013e3181bad05d","article-title":"Fenofibrate enhances neovascularization in a murine ischemic hindlimb model","volume":"54","author":"A Katayama","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6A","key":"pone.0235362.ref009","doi-asserted-by":"crossref","first-page":"3C","DOI":"10.1016\/j.amjcard.2006.11.016","article-title":"Safety considerations with fibrate therapy","volume":"99","author":"MH Davidson","year":"2007","journal-title":"Am J Cardiol"},{"key":"pone.0235362.ref010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","article-title":"2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"253","author":"Authors\/Task Force M","year":"2016","journal-title":"Atherosclerosis"},{"issue":"39","key":"pone.0235362.ref011","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias","volume":"37","author":"AL Catapano","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"pone.0235362.ref012","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030706","article-title":"Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-alpha Modulator (SPPARMalpha), in Dyslipidemic Patients with Renal Impairment","volume":"20","author":"K Yokote","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"22","key":"pone.0235362.ref013","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225537","article-title":"Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor alpha Modulator (SPPARMalpha): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination","volume":"20","author":"S Yamashita","year":"2019","journal-title":"Int J Mol Sci"},{"key":"pone.0235362.ref014","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.atherosclerosis.2016.03.003","article-title":"The novel selective PPARalpha modulator (SPPARMalpha) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis","volume":"249","author":"N Hennuyer","year":"2016","journal-title":"Atherosclerosis"},{"issue":"1","key":"pone.0235362.ref015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm.3014","article-title":"Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine","volume":"19","author":"KH Kim","year":"2013","journal-title":"Nat Med"},{"issue":"47","key":"pone.0235362.ref016","doi-asserted-by":"crossref","first-page":"32802","DOI":"10.1074\/jbc.M803440200","article-title":"Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism","volume":"283","author":"N Ouchi","year":"2008","journal-title":"J Biol Chem"},{"issue":"40","key":"pone.0235362.ref017","doi-asserted-by":"crossref","first-page":"34552","DOI":"10.1074\/jbc.M111.277319","article-title":"Adipolin\/C1qdc2\/CTRP12 protein functions as an adipokine that improves glucose metabolism","volume":"286","author":"T Enomoto","year":"2011","journal-title":"J Biol Chem"},{"issue":"2","key":"pone.0235362.ref018","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1074\/jbc.M310389200","article-title":"Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells","volume":"279","author":"N Ouchi","year":"2004","journal-title":"J Biol Chem"},{"issue":"27","key":"pone.0235362.ref019","doi-asserted-by":"crossref","first-page":"28670","DOI":"10.1074\/jbc.M402558200","article-title":"Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling","volume":"279","author":"R Shibata","year":"2004","journal-title":"J Biol Chem"},{"issue":"2","key":"pone.0235362.ref020","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/01.RES.0000200740.57764.52","article-title":"Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction","volume":"98","author":"G Galasso","year":"2006","journal-title":"Circ Res"},{"issue":"13","key":"pone.0235362.ref021","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/MCB.00126-09","article-title":"Adiponectin promotes revascularization of ischemic muscle through a cyclooxygenase 2-dependent mechanism","volume":"29","author":"K Ohashi","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"29","key":"pone.0235362.ref022","doi-asserted-by":"crossref","first-page":"22291","DOI":"10.1074\/jbc.M110.123794","article-title":"LKB1 deficiency in Tie2-Cre-expressing cells impairs ischemia-induced angiogenesis","volume":"285","author":"K Ohashi","year":"2010","journal-title":"J Biol Chem"},{"issue":"8","key":"pone.0235362.ref023","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/01.RES.0000163633.10240.3b","article-title":"AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle","volume":"96","author":"N Ouchi","year":"2005","journal-title":"Circ Res"},{"issue":"14","key":"pone.0235362.ref024","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCULATIONAHA.112.115089","article-title":"Therapeutic Impact of Follistatin-like 1 on Myocardial Ischemic Injury in Preclinical Animal Models","volume":"126","author":"Y Ogura","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"pone.0235362.ref025","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.110.236174","article-title":"The actin-binding protein Girdin and its Akt-mediated phosphorylation regulate neointima formation after vascular injury","volume":"108","author":"H Miyake","year":"2011","journal-title":"Circ Res"},{"key":"pone.0235362.ref026","article-title":"Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation","author":"Y Uemura","year":"2012","journal-title":"FASEB J"},{"issue":"11","key":"pone.0235362.ref027","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1172\/JCI1560","article-title":"Nitric oxide synthase modulates angiogenesis in response to tissue ischemia","volume":"101","author":"T Murohara","year":"1998","journal-title":"J Clin Invest"},{"issue":"21","key":"pone.0235362.ref028","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1161\/CIRCULATIONAHA.115.015308","article-title":"Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice","volume":"131","author":"Z Lin","year":"2015","journal-title":"Circulation"},{"issue":"8","key":"pone.0235362.ref029","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.tem.2019.05.007","article-title":"Going Back to the Biology of FGF21: New Insights","volume":"30","author":"JE Lewis","year":"2019","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"pone.0235362.ref030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072148","article-title":"The Peroxisome Proliferator-Activated Receptor alpha (PPARalpha) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice","volume":"19","author":"M Araki","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"12","key":"pone.0235362.ref031","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.2337\/db14-0595","article-title":"Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding","volume":"63","author":"KR Markan","year":"2014","journal-title":"Diabetes"},{"issue":"6736","key":"pone.0235362.ref032","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/21218","article-title":"Regulation of endothelium-derived nitric oxide production by the protein kinase Akt","volume":"399","author":"D Fulton","year":"1999","journal-title":"Nature"},{"issue":"6736","key":"pone.0235362.ref033","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/21224","article-title":"Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation","volume":"399","author":"S Dimmeler","year":"1999","journal-title":"Nature"},{"issue":"4","key":"pone.0235362.ref034","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI9419","article-title":"Acute modulation of endothelial Akt\/PKB activity alters nitric oxide-dependent vasomotor activity in vivo","volume":"106","author":"Z Luo","year":"2000","journal-title":"J Clin Invest"},{"issue":"4","key":"pone.0235362.ref035","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bbrc.2006.01.052","article-title":"Fenofibrate activates AMPK and increases eNOS phosphorylation in HUVEC","volume":"341","author":"H Murakami","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"15\u201316","key":"pone.0235362.ref036","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.lfs.2008.02.002","article-title":"PPARalpha activators upregulate eNOS activity and inhibit cytokine-induced NF-kappaB activation through AMP-activated protein kinase activation","volume":"82","author":"T Okayasu","year":"2008","journal-title":"Life Sci"},{"issue":"4","key":"pone.0235362.ref037","doi-asserted-by":"crossref","first-page":"E560","DOI":"10.1152\/ajpendo.00284.2010","article-title":"Fenofibrate promotes ischemia-induced revascularization through the adiponectin-dependent pathway","volume":"299","author":"P Li","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"pone.0235362.ref038","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cmet.2013.04.005","article-title":"Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice","volume":"17","author":"Z Lin","year":"2013","journal-title":"Cell Metab"},{"issue":"5","key":"pone.0235362.ref039","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","article-title":"An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice","volume":"17","author":"WL Holland","year":"2013","journal-title":"Cell Metab"},{"issue":"6","key":"pone.0235362.ref040","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/jdi.12845","article-title":"Effects of a novel selective peroxisome proliferator-activated receptor-alpha modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance","volume":"9","author":"I Matsuba","year":"2018","journal-title":"J Diabetes Investig"},{"issue":"8","key":"pone.0235362.ref041","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708791","article-title":"FGF21 gene therapy as treatment for obesity and insulin resistance","volume":"10","author":"V Jimenez","year":"2018","journal-title":"EMBO Mol Med"},{"issue":"1","key":"pone.0235362.ref042","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbrc.2015.02.081","article-title":"FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism","volume":"459","author":"Y Joki","year":"2015","journal-title":"Biochem Biophys Res Commun"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T17:44:06Z","timestamp":1593107046000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235362"}},"subtitle":[],"editor":[{"given":"Masuko","family":"Ushio-Fukai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,6,25]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0235362","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,25]]}}}